ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Infectious Diseases |
Manuscript Type |
Observational Study |
Article Title |
Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Arantza Sanvisens, Inmaculada Rivas, Eva Faure, Néstor Espinach, Anna Hernandez-Rubio, Xavier Majó, Joan Colom and Robert Muga |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
the Ministry of Science, Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain |
RD16/0017/0003 |
the Ministry of Science, Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain |
PI17/00174 |
the Ministry of Science, Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain |
INT19/00026 |
the Ministry of Science, Innovation and Universities, Carlos III Health Institute (ISCIII), European Fund for Regional Development (FEDER), Network for Cooperative Research in Health (RETICS), Spain |
CD19/00019 |
the Ministry of Health, National Plan on Drugs (PNSD), Spain |
2018/020 |
the European Commission (806996-JUSTSO-JUST2017-AG-DRUG) |
|
the Gilead Fellowship Program, Gilead Sciences |
GLD17/187 |
the Ministry of Education, Spain |
PRX18/00245 |
the Agency for Management of University and Research Grants, Government of Catalonia |
2017SGR316 |
the Municipal Institute of Personal Services-IMSP, Badalona |
|
|
Corresponding Author |
Robert Muga, MD, PhD, Professor, Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Ctra. canyet s/n, Badalona 08916, Spain. rmuga.germanstrias@gencat.cat |
Key Words |
Direct-acting antiviral agents; Opioid Treatment Program; Opioid agonist therapy; Hepatitis C virus infection; Human immunodeficiency virus infection; Drug use |
Core Tip |
Longitudinal study carried out in the only Opioid Treatment Program authorized for the provision of methadone or buprenorphine in a large urban area of 360000 inhabitants. Results indicate that hepatitis C virus treatment rates are increasing since the introduction of direct antiviral agents and identifies gaps and challenges on the readiness to treat infection. |
Publish Date |
2020-10-14 11:33 |
Citation |
Sanvisens A, Rivas I, Faure E, Espinach N, Hernandez-Rubio A, Majó X, Colom J, Muga R. Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study. World J Gastroenterol 2020; 26(38): 5874-5883 |
URL |
https://www.wjgnet.com/1007-9327/full/v26/i38/5874.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v26.i38.5874 |